211 related articles for article (PubMed ID: 23101153)
21. Symposium on treatment of diabetic complications. 3. The management of diabetic nephropathy.
Kikkawa R
Intern Med; 1997 Feb; 36(2):141-2. PubMed ID: 9099603
[No Abstract] [Full Text] [Related]
22. [Prevention and remission of diabetic nephropathy].
Sugimoto T; Nakamura Y; Makino H
Nihon Rinsho; 2003 Jul; 61(7):1167-71. PubMed ID: 12877079
[TBL] [Abstract][Full Text] [Related]
23. In patients with chronic diabetic nephropathy, do angiotensin-converting enzyme inhibitors (ACEI) have greater renal protective effect as compared to angiotensin receptor blockers (ARB)?
Tucker S; Chen Y; Abell R
J Okla State Med Assoc; 2013 Jul; 106(7):294-5. PubMed ID: 24032256
[No Abstract] [Full Text] [Related]
24. Detecting and controlling diabetic nephropathy: what do we know?
Appel G
Cleve Clin J Med; 2013 Apr; 80(4):209-17. PubMed ID: 23547091
[TBL] [Abstract][Full Text] [Related]
25. [Prediction, screening and treatment of renal complications of diabetes].
Marre M; Larger E
Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
[TBL] [Abstract][Full Text] [Related]
26. The evolution of treatment guidelines for diabetic nephropathy. Strategies integrate JNC VI, more recent protocols.
Bakris GL
Postgrad Med; 2003 May; 113(5):35-40, 43-4, 50. PubMed ID: 12764895
[TBL] [Abstract][Full Text] [Related]
27. Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?
Gallagher H; Suckling RJ
Diabetes Obes Metab; 2016 Jul; 18(7):641-7. PubMed ID: 26743887
[TBL] [Abstract][Full Text] [Related]
28. Targeting hypertension in patients with cardiorenal metabolic syndrome.
Rojas E; Velasco M; Bermúdez V; Israili Z; Bolli P
Curr Hypertens Rep; 2012 Oct; 14(5):397-402. PubMed ID: 22846983
[TBL] [Abstract][Full Text] [Related]
29. [Diabetic nephropathy and nephrotic syndrome].
Wada T
Nihon Jinzo Gakkai Shi; 2010; 52(7):908-13. PubMed ID: 21077340
[No Abstract] [Full Text] [Related]
30. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
31. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.
Nielsen FS
Dan Med Bull; 2000 Sep; 47(4):249-70. PubMed ID: 11064829
[No Abstract] [Full Text] [Related]
32. [Management of diabetic nephropathy with nephrotic syndrome].
Eguchi J; Wada J; Makino H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():430-6. PubMed ID: 12430265
[No Abstract] [Full Text] [Related]
33. [Diagnosis of and therapy for patients with diabetic nephropathy].
Doi T
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):569-73. PubMed ID: 15052822
[No Abstract] [Full Text] [Related]
34. Update on Diabetic Nephropathy: Core Curriculum 2018.
Umanath K; Lewis JB
Am J Kidney Dis; 2018 Jun; 71(6):884-895. PubMed ID: 29398179
[TBL] [Abstract][Full Text] [Related]
35. [Evidence based treatment of diabetic nephropathy].
Sugimoto T
Nihon Rinsho; 2002 Oct; 60 Suppl 10():294-300. PubMed ID: 12430244
[No Abstract] [Full Text] [Related]
36. Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Sternlicht H; Bakris GL
Blood Purif; 2016; 41(1-3):139-43. PubMed ID: 26766168
[TBL] [Abstract][Full Text] [Related]
37. Do angiotensin II antagonists provide benefits beyond blood pressure reduction?
de Champlain J
Adv Ther; 2005; 22(2):117-36. PubMed ID: 16020402
[TBL] [Abstract][Full Text] [Related]
38. [Progress in diagnosis of and therapy for diabetic complication--diabetic nephropathies].
Haneda M
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):773-8. PubMed ID: 19472530
[No Abstract] [Full Text] [Related]
39. [A threat to cardiovascular risk patients. "Activated renin-angiotensin system promotes end organ damage" (interview by Waldtraud Paukstadt)].
Schunkert H
MMW Fortschr Med; 2004 Jun; 146(23):60. PubMed ID: 15373137
[No Abstract] [Full Text] [Related]
40. Therapeutic options in diabetic renal disease and hypertension.
Savage MW; Leese GP; Chattington P; Vora JP
Br J Hosp Med; 1995 Nov 1-14; 54(9):429-34. PubMed ID: 8564177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
